Placebo - Sodium Chloride 9 mg/ml (0.9%) - Solution for injection, ARO-DM1
ARODM1-1001
Phase 2 small_molecule active
Quick answer
Placebo - Sodium Chloride 9 mg/ml (0.9%) - Solution for injection, ARO-DM1 for Type 1 Myotonic Dystrophy is a Phase 2 program (small_molecule) at Sarepta Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sarepta Therapeutics
- Indication
- Type 1 Myotonic Dystrophy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active